🚨Moving towards a sustainable academic society - editorial by our ESMO - Eur. Oncology #ClimateChange Task Force is out in ESMO Open
🚨ESMO members, on average, use up almost 75% of their annual CO2 budget by attending the annual congress
more ⏩esmoopen.com/article/S2059-… Joakim Crona, MD

📣📣📣 Dear colleagues & ESMO - Eur. Oncology members, please help us to understand more about current role & future potential of #DigitalHealth technology in #oncology 💻

📋Link to our #ESMOYOC survey:
esmo.eu.qualtrics.com/jfe/form/SV_4V…

Matteo Lambertini, MD PhD Andres Cervantes Evandro de Azambuja, MD, PhD francescalongo

“I’m looking forward to the #EACR2024  Congress in Rotterdam. Take a look at the fantastic programme, with lots of vital opportunities for networking and presenting your own research: 2024.eacr.org”.

It takes less than 7 min to complete

To all #YoungOncologists and ESMO - Eur. Oncology member: have you received #ESMOYOC email today?
Don’t miss the opportunity to submit your case for the next #YO4YO session with super faculty Ben Westphalen & Myrto K. Moutafi !!!!

Here the link:
esmo.formstack.com/forms/esmo_yo_…

“I’m looking forward to the #EACR2024  Congress in Rotterdam. Take a look at the fantastic programme, with lots of vital opportunities for networking and presenting your own research: 2024.eacr.org”.

It takes less than 7 min to complete

Dear colleagues & ESMO - Eur. Oncology members, please help us to understand more about current role & future potential of #DigitalHealth technology in #oncology

Link to our #ESMOYOC survey:
esmo.eu.qualtrics.com/jfe/form/SV_cO…

OncoAlert Pablo Mando Andres Cervantes Evandro de Azambuja, MD, PhD francescalongo

‼️Apply now for the amazing ESMO - Eur. Oncology Virtual Mentorship Program! ⬇️
We built this to help shape young oncologist careers around the 🌍 and we'll match you up with some of the greatest ⭐ in oncology!

#ICHNO24 : Don't miss the chance to attend the International Congress on Innovative Approaches in Head and Neck Oncology (9th ICHNO), where ESMO, ESTRO and EHNS News will showcase cutting-edge science and innovation in #HeadAndNeckOncology .
Register 👉ow.ly/AQVb50Qb0xu

#ELCC24 Young thoracic oncologists attention! Join the #ESMOYOC Clincial Cases Discussion at 17:00 in Club A for Advanced rare mutations, Primary resistance to immunotherapy, Brain mets and more Umberto Malapelle Ilit Turgeman Noemi Reguart Elene Mariamidze Myrto K. Moutafi ESMO - Eur. Oncology IASLC

❤️ #ELCC24 #ESMO #ESMO YOC thank Elene Mariamidze and Hongcheng Zhu 祝鸿程

👉PAVE trial : Assessing alternative chemo-immunotherapy sequencing yields comparable outcomes to SoC in ES-SCLC Giannis Mountzios #ELCC24 #HeCOG #ESMO

With #ELCC24 ready to kick-off, don't miss‼️👇
(CET)
✅WED 13:30 Opening session
✅WED 16:30 IO resistance
✅THU 15:10 Proffered papers
✅THU 08:00 Liquid Bx debate
✅Mini orals 1⃣ Wed 16:30 2⃣ Thu 17:00 3⃣ Fr 08:15
✅ SAT 10:00 ADCs
✅ Posters🎖️
...more‼️
#LCSM IASLC @myesmo

Join us at the ESMO YOC mentorship session in the foyer at the ELCC conference! See you there at 15:45 today! Elene Mariamidze Hongcheng Zhu 祝鸿程 #ELCC #YOC #Oncology #Mentorship

Two posters and an active participation of the Greek sarcoma group at the #EsmoSarcomaAndRareCancers2024 IOANNIS BOUKOVINAS Stefania Kokkali ANASTASIOS KYRIAZOGLOU

Join us tomorrow for another great #ESMOYOC YO4YO Virtual Session with Angela Lamarca 🎉🎉

We will discuss the application to a research fellowship to boost your career 🌟🌟

ESMO - Eur. Oncology OncoAlert OncoDaily Matteo Lambertini, MD PhD Myrto K. Moutafi Hongcheng Zhu 祝鸿程 Liz Connolly Pawel Sobczuk…

🌟 Calling all young oncologists! 🌟 Join the ESMO Virtual Mentorship Program! 🎓 👉 ESMO members <40, ✌️skill development, career advice, and research guidance🤓->in just 12 months! Apply now! #ESMO #Mentorship 🚀👩‍🔬👨‍🔬 #ESMO YOC
esmo.org/career-develop…

Σήμερα στο 15ο Μετεκπαιδευτικό Σεμινάριο Κλινικής και Ερευνητικής Ογκολογίας Miriam Anastasiou ANASTASIOS KYRIAZOGLOU ευχαριστούμε πολύ :) Amanda Psyrri #AttikonUniHospital #OncologyResearch 👩‍🔬

Activity of anti-Her2 ADC T-DXd for cerebral metastases is truly remarkable🧠📷 As these patients are often excluded from trials, it's crucial to conduct more ADC trials in this challenging population, e.g. like TUXEDO-1 Paolo Tarantino ESMO Open @oncoalert UroToday.com Top Biomedical Science